Key Highlights
- Dan Zortman appointed as the new CEO of Sysmex America, Inc.
- Andy Hay to continue as Chairman and President.
- Zortman brings over 33 years of diagnostics industry experience.
- Focus on advancing Sysmex America’s long-term strategy and growth.
Source: PR Newswire
Notable Quotes
- “It’s an honor to join Sysmex America, a trusted global leader respected for optimizing the efficiency, operations and financial performance of clinical laboratories.” — Dan Zortman, CEO at Sysmex America, Inc
- “Dan is exceptionally well-suited to advance our long-term strategy and accelerate growth. He is a strategic and customer-focused leader who understands our organization’s deep sense of purpose.” — Andy Hay, Chairman and President at Sysmex America, Inc
SoHC's Take
The appointment of Dan Zortman as the new CEO of Sysmex America, Inc. is a strategic move to further solidify the company’s leadership in the diagnostic solutions industry. Zortman’s extensive experience in the diagnostics sector, particularly his successful tenure at Roche, positions him well to drive Sysmex America’s growth and innovation. His leadership will be crucial as the healthcare industry continues to evolve from volume-based to value-based care. With Andy Hay’s continued involvement as Chairman and President, Sysmex America is poised to enhance its market presence and technological advancements, especially with the emerging hinotori™ Surgical Robotic System business. This transition plan indicates a robust strategy aimed at sustaining long-term success and operational excellence.
